23andMe, based in Sunnyvale, CA, provides DNA testing with comprehensive ancestry insights and personalized health reports. Founded in 2006, it aims to help people understand and benefit from the human genome. As a leader in consumer genetics, 23andMe holds multiple FDA authorizations for health risk reports and boasts the largest crowdsourced genetic research platform, contributing to over 180 scientific publications. Their Therapeutics division focuses on drug discovery in various disease areas. The company has received accolades as a top workplace, and CEO Anne Wojcicki has been recognized for her leadership. For more information, visit www.23andMe.com.